Pharmaniaga Bhd - Asset Resilience Ratio
Pharmaniaga Bhd (7081) has an Asset Resilience Ratio of 6.59% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Pharmaniaga Bhd balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2025)
This chart shows how Pharmaniaga Bhd's Asset Resilience Ratio has changed over time. See shareholders equity of Pharmaniaga Bhd for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Pharmaniaga Bhd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 7081 stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RM0.00 | 0% |
| Short-term Investments | RM147.98 Million | 6.59% |
| Total Liquid Assets | RM147.98 Million | 6.59% |
Asset Resilience Insights
- Limited Liquidity: Pharmaniaga Bhd maintains only 6.59% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Pharmaniaga Bhd Industry Peers by Asset Resilience Ratio
Compare Pharmaniaga Bhd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Cyclopharm Ltd
AU:CYC |
Medical Distribution | 1.98% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607 |
Medical Distribution | 4.21% |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332 |
Medical Distribution | 0.00% |
Annual Asset Resilience Ratio for Pharmaniaga Bhd (2012–2025)
The table below shows the annual Asset Resilience Ratio data for Pharmaniaga Bhd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.59% | RM147.98 Million ≈ $37.15 Million |
RM2.25 Billion ≈ $564.10 Million |
+6.16pp |
| 2024-12-31 | 0.43% | RM8.57 Million ≈ $2.15 Million |
RM1.99 Billion ≈ $500.20 Million |
+0.28pp |
| 2023-12-31 | 0.15% | RM2.87 Million ≈ $719.31K |
RM1.91 Billion ≈ $480.76 Million |
-0.07pp |
| 2022-12-31 | 0.22% | RM4.11 Million ≈ $1.03 Million |
RM1.85 Billion ≈ $463.79 Million |
-0.23pp |
| 2021-12-31 | 0.45% | RM10.25 Million ≈ $2.57 Million |
RM2.26 Billion ≈ $566.87 Million |
-0.69pp |
| 2020-12-31 | 1.15% | RM18.13 Million ≈ $4.55 Million |
RM1.58 Billion ≈ $396.73 Million |
+0.39pp |
| 2019-12-31 | 0.76% | RM12.13 Million ≈ $3.05 Million |
RM1.59 Billion ≈ $399.77 Million |
+0.07pp |
| 2018-12-31 | 0.69% | RM13.12 Million ≈ $3.30 Million |
RM1.91 Billion ≈ $478.97 Million |
-- |
| 2017-12-31 | 0.00% | RM0.00 ≈ $0.00 |
RM1.61 Billion ≈ $403.65 Million |
-- |
| 2016-12-31 | 0.00% | RM0.00 ≈ $0.00 |
RM1.68 Billion ≈ $422.57 Million |
-- |
| 2015-12-31 | 0.20% | RM3.00 Million ≈ $753.20K |
RM1.50 Billion ≈ $375.60 Million |
+0.04pp |
| 2014-12-31 | 0.16% | RM2.00 Million ≈ $502.13K |
RM1.24 Billion ≈ $312.08 Million |
-0.38pp |
| 2013-12-31 | 0.54% | RM6.00 Million ≈ $1.51 Million |
RM1.11 Billion ≈ $278.94 Million |
+0.38pp |
| 2012-12-31 | 0.16% | RM2.00 Million ≈ $502.13K |
RM1.22 Billion ≈ $307.05 Million |
-- |
About Pharmaniaga Bhd
Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines… Read more